Sponsored by
This is one of the more exciting treatments in the pipeline, but unfortunately this trial did not show good results for most of the patients. 2 patients out of 18 did well. There are many variations of CAR-T cells, using many different targets. This doesn't mean all Car-t cell trials won't work.